Antibody-dependent cellular phagocytosis by human breastmilk leukocytes: impact of antibody class, stage of lactation, and target size

人母乳白细胞的抗体依赖性细胞吞噬作用:抗体类别、哺乳阶段和目标大小的影响

基本信息

  • 批准号:
    9789908
  • 负责人:
  • 金额:
    $ 21.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-21 至 2021-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary Mother-to-child transmission (MTCT) of HIV remains a crisis in resource-limited countries where HIV is prevalent. Approximately 200,000 MTCTs of HIV occur annually, with as many as half of infections being due to exposure via breastmilk (BM) [1, 2]. Yet, only ~10-15% of infants breastfed by HIV-infected mothers actually become infected, suggesting a strong protective effect of BM itself [1-5]. Though multiple studies have demonstrated the protective effect of human BM against HIV MTCT [1-10], the contribution of the milk’s cellular component has been relatively overlooked, despite evidence that maternal leukocytes are functional beyond the sites of ingestion [11-15]. The only clinical HIV vaccine trial to show efficacy, RV144, and many other studies have correlated activities mediated by the constant (Fc) Ab domain with protection from HIV acquisition and this is documented similarly with other pathogens [16-29]. Though demonstrated as necessary for the clearance of numerous viral infections, one essential Fc-mediated response--Ab-dependent cellular phagocytosis (ADCP)--has been relatively understudied in the context of HIV, particularly in the case of prevention of MTCT [30-37]. Colostral phagocytes can perform ADCP of bacteria, parasites and yeast opsonized with maternal Abs; however, this has not been studied with regard to HIV or HIV-infected cells [38- 44]. Furthermore, the potential contribution of ADCP to protection from MTCT of HIV has not been studied with regard to impact of phagocytic target size (e.g., cell-free and cell-associated virus), or the effects of the dynamic leukocyte composition of BM over the lactation period [45-50]. Only conflicting and/or small studies have been conducted regarding the relevance of Ab subclass in Fc-mediated activity, especially in BM [16, 42, 51-57]. Given the substantial gap in present knowledge of the potential contribution of ADCP activity by BM phagocytes to prevention of MTCT of HIV, it is critical to develop a multidimensional, comprehensive understanding of ADCP by the relevant primary cells in BM. The proposed study aims to fill this knowledge gap. AIM 1 will address the impact of phagocytic target size/type on ADCP by BM cells, AIM 2 will address the impact of Ab class on ADCP by BM cells, and AIM 3 will address the impact of BM maturation over time on ADCP activity. These data will allow the field to better understand the potential contribution of ADCP mediated by BM cells to the reduction of MTCT of HIV, and may well be applicable to other pathogens that threaten infants over the course of lactation.
项目概要 在艾滋病毒流行的资源有限国家,艾滋病毒母婴传播(MTCT)仍然是一场危机 流行。每年大约发生 20 万例 HIV 母婴传播,其中多达一半的感染是由于 通过母乳接触 (BM) [1, 2]。然而,只有 10-15% 的婴儿实际上是由感染艾滋病毒的母亲母乳喂养的 被感染,表明BM本身具有很强的保护作用[1-5]。尽管多项研究表明 证明了人类母乳对 HIV 母婴传播的保护作用 [1-10],这是乳汁细胞的贡献 尽管有证据表明母体白细胞的功能超出了 摄入部位[11-15]。唯一显示疗效的临床 HIV 疫苗试验、RV144 以及许多其他疫苗 研究将恒定 (Fc) Ab 结构域介导的活性与防止 HIV 感染的保护联系起来 其他病原体也有类似的记录[16-29]。尽管已被证明是必要的 清除多种病毒感染,一种重要的 Fc 介导的反应——Ab 依赖性细胞 吞噬作用(ADCP)——在艾滋病毒的背景下,人们对吞噬作用的研究相对较少,特别是在艾滋病毒的情况下 预防母婴传播[30-37]。初乳吞噬细胞可以对细菌、寄生虫和酵母进行 ADCP 与母体 Abs 调理;然而,尚未对 HIV 或 HIV 感染细胞进行研究 [38- 44]。此外,尚未研究 ADCP 对预防 HIV 母婴传播的潜在贡献 关于吞噬目标大小(例如,无细胞和细胞相关病毒)的影响,或 哺乳期骨髓的动态白细胞组成[45-50]。仅存在冲突和/或小型研究 已经针对 Ab 亚类在 Fc 介导的活性中的相关性进行了研究,特别是在 BM 中 [16, 42, 51-57]。鉴于目前对 BM 对 ADCP 活动的潜在贡献的了解还存在巨大差距 吞噬细胞对预防艾滋病毒母婴传播至关重要,开发多维、综合的方法至关重要 BM 中相关原代细胞对 ADCP 的理解。拟议的研究旨在填补这些知识 差距。 AIM 1 将解决吞噬目标大小/类型对 BM 细胞 ADCP 的影响,AIM 2 将解决 Ab 类别对 BM 细胞 ADCP 的影响,AIM 3 将解决 BM 成熟随着时间的推移对 ADCP 的影响 ADCP 活动。这些数据将使该领域更好地了解 ADCP 介导的潜在贡献 BM 细胞可减少 HIV 母婴传播,并且很可能适用于威胁其他病原体 哺乳期的婴儿。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rebecca Powell其他文献

Rebecca Powell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rebecca Powell', 18)}}的其他基金

Comprehensive assessment of SARS-CoV-2-reactive antibodies in human milk to determine their potential as a COVID-19 therapeutic and as a means to prevent infection of breastfed babies
对人乳中的 SARS-CoV-2 反应性抗体进行全面评估,以确定其作为 COVID-19 治疗药物和预防母乳喂养婴儿感染的手段的潜力
  • 批准号:
    10470802
  • 财政年份:
    2020
  • 资助金额:
    $ 21.19万
  • 项目类别:
Antibody-dependent cellular phagocytosis by human breastmilk leukocytes: impact of antibody class, stage of lactation, and target size
人母乳白细胞的抗体依赖性细胞吞噬作用:抗体类别、哺乳阶段和目标大小的影响
  • 批准号:
    10222911
  • 财政年份:
    2020
  • 资助金额:
    $ 21.19万
  • 项目类别:
Comprehensive assessment of SARS-CoV-2-reactive antibodies in human milk to determine their potential as a COVID-19 therapeutic and as a means to prevent infection of breastfed babies
对人乳中的 SARS-CoV-2 反应性抗体进行全面评估,以确定其作为 COVID-19 治疗药物和预防母乳喂养婴儿感染的手段的潜力
  • 批准号:
    10177618
  • 财政年份:
    2020
  • 资助金额:
    $ 21.19万
  • 项目类别:
Comprehensive assessment of SARS-CoV-2-reactive antibodies in human milk to determine their potential as a COVID-19 therapeutic and as a means to prevent infection of breastfed babies
对人乳中的 SARS-CoV-2 反应性抗体进行全面评估,以确定其作为 COVID-19 治疗药物和预防母乳喂养婴儿感染的手段的潜力
  • 批准号:
    10240336
  • 财政年份:
    2020
  • 资助金额:
    $ 21.19万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了